Drug intelligence / Profile preview

3-[1-(4-bromo-phenyl)-2-methyl-propyl]-4-hydroxy-chromen-2-one

Development stage
Unknown
Modality
Small Molecules
01

Overview

**Description:** 3-[1-(4-bromo-phenyl)-2-methyl-propyl]-4-hydroxy-chromen-2-one is a synthetic small molecule belonging to the class of coumarins, specifically a chromenone derivative. It features a brominated phenyl group and a hydroxy group at the chromenone core. This compound is structurally related to other coumarin derivatives, which are known for their anticoagulant and anti-inflammatory properties. However, this specific compound is classified as experimental and has not been approved for any therapeutic use or entered clinical trials beyond preclinical investigation[1][2][8]. Its mechanism of action has not been established in the literature or major drug databases[9]. The compound may have potential anti-inflammatory activity based on its chemical class but lacks published pharmacological data.

Other names
3-[1-(4-bromo-phenyl)-2-methyl-propyl]-4-hydroxy-chromen-2-one3-[1-(4-bromophenyl)-2-methylpropyl]-4-hydroxychromen-2-one3-(1-(4-Bromo-phenyl)-2-methyl-propyl)-4-hydroxy-chromen-2-one3-[1-(4-bromophenyl)-2-methylpropyl]-4-hydroxychromenone

Beyond the preview

Go deeper on 3-[1-(4-bromo-phenyl)-2-methyl-propyl]-4-hydroxy-chromen-2-one.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-[1-(4-bromo-phenyl)-2-methyl-propyl]-4-hydroxy-chromen-2-one.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call